Literature DB >> 2296976

Kaposi's sarcoma in a cohort of homosexual and bisexual men. Epidemiology and analysis for cofactors.

A R Lifson1, W W Darrow, N A Hessol, P M O'Malley, J L Barnhart, H W Jaffe, G W Rutherford.   

Abstract

Acquired immunodeficiency syndrome (AIDS) surveillance data for both the United States and San Francisco indicate that Kaposi's sarcoma is more common in homosexual and bisexual men with AIDS than in other adults with AIDS, and that the proportion of newly diagnosed AIDS cases presenting with Kaposi's sarcoma has been significantly declining over time. The changing epidemiology of Kaposi's sarcoma was analyzed in a well-characterized cohort of homosexual and bisexual men; laboratory and interview data from a sample of these men were evaluated for determinants of and cofactors associated with Kaposi's sarcoma. Among 1,341 men with AIDS, the proportion presenting with Kaposi's sarcoma declined from 79% in 1981 to 25% in 1989. Compared with other men with AIDS, men with Kaposi's sarcoma had a shorter interval from human immunodeficiency virus (HIV) seroconversion to AIDS diagnosis (median, 77 vs. 86 months). Men with and without Kaposi's sarcoma did not significantly differ with respect to number of sexual partners, history of certain sexually transmitted or enteric diseases, use of certain recreational drugs (including nitrite inhalants), or participation in certain specific sexual practices. The decline in Kaposi's sarcoma may at least partly be due to a shorter latency period from infection to disease. Although cofactors for the development of Kaposi's sarcoma may exist, many previously hypothesized agents were not supported by this analysis.

Entities:  

Mesh:

Year:  1990        PMID: 2296976     DOI: 10.1093/oxfordjournals.aje.a115492

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  8 in total

1.  Oro-anal sex and the occurrence of Kaposi's sarcoma.

Authors:  G J van Griensven; E C Boucher; R A Coutinho
Journal:  Genitourin Med       Date:  1993-02

2.  Is risk of Kaposi's sarcoma in AIDS patients in Britain increased if sexual partners came from United States or Africa?

Authors:  V Beral; D Bull; H Jaffe; B Evans; N Gill; H Tillett; A J Swerdlow
Journal:  BMJ       Date:  1991-03-16

3.  The chemical bases of the various AIDS epidemics: recreational drugs, anti-viral chemotherapy and malnutrition.

Authors:  Peter Duesberg; Claus Koehnlein; David Rasnick
Journal:  J Biosci       Date:  2003-06       Impact factor: 1.826

4.  Opportunistic diseases in HIV-infected patients in Gabon following the administration of highly active antiretroviral therapy: a retrospective study.

Authors:  Madeleine Okome-Nkoumou; Vincent Guiyedi; Magloire Ondounda; Nora Efire; Philippe Clevenbergh; Mireille Dibo; Arnaud Dzeing-Ella
Journal:  Am J Trop Med Hyg       Date:  2013-12-09       Impact factor: 2.345

5.  Cell-associated infectious HIV-1 viral load as a predictor of clinical progression and survival among HIV-1 infected injection drug users and homosexual men.

Authors:  C M Lyles; N M Graham; J Astemborski; D Vlahov; J B Margolick; A J Saah; H Farzadegan
Journal:  Eur J Epidemiol       Date:  1999-02       Impact factor: 8.082

6.  Evidence for multiclonality in multicentric Kaposi's sarcoma.

Authors:  P S Gill; Y C Tsai; A P Rao; C H Spruck; T Zheng; W A Harrington; T Cheung; B Nathwani; P A Jones
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

Review 7.  Measuring inhalant nitrite exposure in gay men: implications for elucidating the etiology of AIDS-related Kaposi's sarcoma.

Authors:  H W Haverkos; D P Drotman
Journal:  Genetica       Date:  1995       Impact factor: 1.082

8.  Long-term nitrite inhalant exposure and cancer risk in MSM.

Authors:  Anupriya Dutta; Hajime Uno; Alex Holman; David R Lorenz; Steven M Wolinsky; Dana Gabuzda
Journal:  AIDS       Date:  2017-05-15       Impact factor: 4.177

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.